Review



onco type dx® colon cancer assay  (Genomic Health Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Genomic Health Inc onco type dx® colon cancer assay
    Onco Type Dx® Colon Cancer Assay, supplied by Genomic Health Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/onco+type+dx%C2%AE+colon+cancer+assay/12+gene+recurrence+score+assay+oncotype+dx+colon+recurrence+score+assay/pmc04912774-48-1-9
    Average 90 stars, based on 1 article reviews
    onco type dx® colon cancer assay - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer
    Article Snippet: The Onco type DX® Colon Cancer Assay (12-gene assay, Genomic Health, Inc., Redwood City, California) is a 12-gene RT-PCR based test that yields a Recurrence Score® result that has been clinically validated to predict the probability of recurrence following resection of stage II and stage III colon cancer [ – ].



    Similar Products

    onco type dx® colon cancer assay  (Genomic Health Inc)
    90
    Genomic Health Inc onco type dx® colon cancer assay
    Onco Type Dx® Colon Cancer Assay, supplied by Genomic Health Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/onco+type+dx%C2%AE+colon+cancer+assay/12+gene+recurrence+score+assay+oncotype+dx+colon+recurrence+score+assay/pmc04912774-48-1-9
    Average 90 stars, based on 1 article reviews
    onco type dx® colon cancer assay - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    onco type dx colon cancer assay  (Genomic Health Inc)
    90
    Genomic Health Inc onco type dx colon cancer assay
    NCCN Guidelines Recommendations for Selected PM Biomarker Testing
    Onco Type Dx Colon Cancer Assay, supplied by Genomic Health Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/onco+type+dx%C2%AE+colon+cancer+assay/oncotype+dx+colon+cancer+assay/pmc03695822-106-40-46
    Average 90 stars, based on 1 article reviews
    onco type dx colon cancer assay - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    onco type dx colon cancer test  (Genomic Health Inc)
    90
    Genomic Health Inc onco type dx colon cancer test
    Features of the <t> Onco type DX Colon Cancer Test </t> and <t> ColoPrint </t> Assay
    Onco Type Dx Colon Cancer Test, supplied by Genomic Health Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/onco+type+dx%C2%AE+colon+cancer+assay/oncotype+dx+colon+cancer+assay/pmc03561586-52-32-38
    Average 90 stars, based on 1 article reviews
    onco type dx colon cancer test - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    onco type dx colon cancer assay  (Tecan Systems)
    90
    Tecan Systems onco type dx colon cancer assay
    Features of the <t> Onco type DX Colon Cancer Test </t> and <t> ColoPrint </t> Assay
    Onco Type Dx Colon Cancer Assay, supplied by Tecan Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/onco+type+dx%C2%AE+colon+cancer+assay/onco+type+dx+colon+cancer+assay/pmc03016296-376-1-15
    Average 90 stars, based on 1 article reviews
    onco type dx colon cancer assay - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    NCCN Guidelines Recommendations for Selected PM Biomarker Testing

    Journal: Journal of the National Comprehensive Cancer Network : JNCCN

    Article Title: Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer

    doi:

    Figure Lengend Snippet: NCCN Guidelines Recommendations for Selected PM Biomarker Testing

    Article Snippet: 30 , 31 The objective for this case study is to describe and compare the available clinical evidence for 4 heterogeneous but contemporary biomarker tests in colorectal cancer: K-ras and B-raf mutation analyses, mismatch repair protein (MMR) testing, and the Onco type DX Colon Cancer Assay (Genomic Health, Inc., Redwood City, California).

    Techniques: Biomarker Discovery, Mutagenesis, Marker

    Clinical Studies of Onco type DX Colon Cancer Assay in Stage II Colon Cancer

    Journal: Journal of the National Comprehensive Cancer Network : JNCCN

    Article Title: Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer

    doi:

    Figure Lengend Snippet: Clinical Studies of Onco type DX Colon Cancer Assay in Stage II Colon Cancer

    Article Snippet: 30 , 31 The objective for this case study is to describe and compare the available clinical evidence for 4 heterogeneous but contemporary biomarker tests in colorectal cancer: K-ras and B-raf mutation analyses, mismatch repair protein (MMR) testing, and the Onco type DX Colon Cancer Assay (Genomic Health, Inc., Redwood City, California).

    Techniques:

    Summary of Search Results

    Journal: Journal of the National Comprehensive Cancer Network : JNCCN

    Article Title: Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer

    doi:

    Figure Lengend Snippet: Summary of Search Results

    Article Snippet: 30 , 31 The objective for this case study is to describe and compare the available clinical evidence for 4 heterogeneous but contemporary biomarker tests in colorectal cancer: K-ras and B-raf mutation analyses, mismatch repair protein (MMR) testing, and the Onco type DX Colon Cancer Assay (Genomic Health, Inc., Redwood City, California).

    Techniques: Mutagenesis

    Features of the Onco type DX Colon Cancer Test and ColoPrint Assay

    Journal: Clinical colorectal cancer

    Article Title: Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?

    doi: 10.1016/j.clcc.2011.03.001

    Figure Lengend Snippet: Features of the Onco type DX Colon Cancer Test and ColoPrint Assay

    Article Snippet: We will then present the current data for GEP as a prognostic factor in this malignancy, focusing upon two new assays for risk assessment in patients with stage II colon cancer, the Onco type DX Colon Cancer test (Genomic Health, Inc., Redwood City, CA) and ColoPrint (Agendia BV, Amsterdam, The Netherlands).

    Techniques: Formalin-fixed Paraffin-Embedded, Biomarker Discovery